AU8665498A - Detection and treatment of breast, gynecological and prostate cancer - Google Patents

Detection and treatment of breast, gynecological and prostate cancer

Info

Publication number
AU8665498A
AU8665498A AU86654/98A AU8665498A AU8665498A AU 8665498 A AU8665498 A AU 8665498A AU 86654/98 A AU86654/98 A AU 86654/98A AU 8665498 A AU8665498 A AU 8665498A AU 8665498 A AU8665498 A AU 8665498A
Authority
AU
Australia
Prior art keywords
gynecological
breast
detection
treatment
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86654/98A
Inventor
Eva M. Rakowicz-Szulczynska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EVA M RAKOWICZ SZULCZYNSKA
Original Assignee
EVA M RAKOWICZ SZULCZYNSKA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EVA M RAKOWICZ SZULCZYNSKA filed Critical EVA M RAKOWICZ SZULCZYNSKA
Publication of AU8665498A publication Critical patent/AU8665498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
AU86654/98A 1997-07-29 1998-07-29 Detection and treatment of breast, gynecological and prostate cancer Abandoned AU8665498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90208797A 1997-07-29 1997-07-29
US08902087 1997-07-29
PCT/US1998/015580 WO1999009047A1 (en) 1997-07-29 1998-07-29 Detection and treatment of breast, gynecological and prostate cancer

Publications (1)

Publication Number Publication Date
AU8665498A true AU8665498A (en) 1999-03-08

Family

ID=25415283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86654/98A Abandoned AU8665498A (en) 1997-07-29 1998-07-29 Detection and treatment of breast, gynecological and prostate cancer

Country Status (4)

Country Link
EP (1) EP1012159A1 (en)
AU (1) AU8665498A (en)
CA (1) CA2297727A1 (en)
WO (1) WO1999009047A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2178341A1 (en) * 1993-10-15 1995-04-20 Eva M. Rakowicz-Szulczynska Detection and treatment of breast and gynecological cancer

Also Published As

Publication number Publication date
WO1999009047A1 (en) 1999-02-25
CA2297727A1 (en) 1999-02-25
EP1012159A1 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
EP0831904A4 (en) Treatment and diagnosis of prostate cancer
AU5089799A (en) Drug complex for treatment of metastatic prostate cancer
AU1939200A (en) Electrochemical treatment of malignant tumors
GB9903841D0 (en) Diagnosis and treatment of cancer
AU5047800A (en) Breast, gastric and prostate cancer associated antigens and uses therefor
AU4473596A (en) Methods of human prostate cancer diagnosis
HUP0001316A3 (en) Method for the detection and localization of malignant human tumours
AUPQ923100A0 (en) Treatment of prostate cancer
AU5005697A (en) Methods of preventing breast cancer
GB9811598D0 (en) Diagnosis and treatment of cancer
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
AU2002327639A1 (en) Detection and treatment of cancers of breast
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU3326000A (en) Means of early examination of malignant tumor
AU8665498A (en) Detection and treatment of breast, gynecological and prostate cancer
GB9819999D0 (en) Treatment of cancer
AU2001297571A1 (en) Detection and treatment of prostate cancer
AU4417996A (en) Treatment of prostate cancer
AU5946999A (en) Tumour therapy and imaging
IL132531A0 (en) Detection and therapy of tumors
AU5939898A (en) Agent for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
AUPO851597A0 (en) Treatment of prostate cancer
AU7130696A (en) Combination of beta-interferon for the treatment of prostate cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase